As number 1 in the pharmaceutical industry in Europe the group?s mission is to find solutions in seven major therapeutical areas : Cardiovascular, thrombosis, metabolic disorders, oncology, central nervous system, internal medicine and vaccines. The group is established in 100 countries over the five continents and dedicates 4 billion euros to research& development.
- Implementation of an action plan focused on initiatives with a strong added value for Sanofi-Aventis (2007-2008) : upgrade of practices based on a benchmark, recommendation of differenciation opportunities, strategic orientations for CSR and innovation (issue on patents).
- Sustainability reporting (2006-2007).
- Production of an international benchmark « Stakeholder dialogue initiatives » in order to juge the relevance of the implementation of a stakeholder panel (2000).